Moderna Falls, Celsius Climbs, Newsmax Skyrockets in Debut
On this episode of Stock Movers:- Vaccine and biotech stocks, including Moderna (MRNA) plunged after a top regulator left the US Food and Drug Administration, casting deep uncertainty about the future of vaccines and cutting-edge gene therapies. Peter Marks, a key figure overseeing the review and approval of vaccines and other medications, resigned on Friday, citing friction with the views of new Health and Human Services Secretary and longtime vaccine critic Robert F. Kennedy Jr. - Celsius Holdings (CELH) shares rose to hit its highest intraday level since September after Truist Securities…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.